Supergenics Berhad

KLSE:SGBHD Stock Report

Market Cap: RM 34.7m

Supergenics Berhad Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Bii Chau Tan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership62.4%
Management average tenure2.7yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Bii Chau Tan (45 yo)

no data

Tenure

Mr. Bii Chau Tan serves as Group Managing Director and Director of Supergenics Berhad. Upon graduation, Mr. Tan began his career in 2001 as a systems and applications engineer with Group Associated C&L Sdn...

Leadership Team

NamePositionTenureCompensationOwnership
Bii Chau Tan
Group MD & Directorno datano data62.41%
MYR 21.7m
Aiman Bin Ramlee
Accounts & Finance Manager7yrsno datano data
Kiat Chan
Head of Corporate Development & Executive Director4.8yrsno datano data
Kien Chua
Executive Director2.7yrsno datano data
Meng Hong Lau
Executive Director1.1yrsno data8.17%
MYR 2.8m
Yuet Wong
Company Secretary2.6yrsno datano data

2.7yrs

Average Tenure

45yo

Average Age

Experienced Management: SGBHD's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bii Chau Tan
Group MD & Directorno datano data62.41%
MYR 21.7m
Kiat Chan
Head of Corporate Development & Executive Director3yrsno datano data
Kien Chua
Executive Director2.7yrsno datano data
Meng Hong Lau
Executive Director1.1yrsno data8.17%
MYR 2.8m
Fun Kim Ng
Independent Non-Executive Director5.8yrsno datano data

2.8yrs

Average Tenure

45yo

Average Age

Experienced Board: SGBHD's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 21:14
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Supergenics Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution